Representative Neal Honored as BIO Legislator of the Year.
Share:
Press Release Summary:
BIO has selected Representative Richard E. Neal (D-MA) as Legislator of the Year for 2008-2009. BIO President and CEO Jim Greenwood said organization commends Congressman Neal for leadership and support of crucial issues affecting biotechnology industry. It also thanks him for support of provision in Economic Recovery Act, which increased funding at National Institutes of Health by $10 billion over next 2 yr. Neal is Chairman of Ways and Means Select Revenue Subcommittee.
Original Press Release:
Representative Neal Honored as BIO Legislator of the Year
WASHINGTON, D.C. (Tuesday, March 31, 2009) - The Biotechnology Industry Organization (BIO) announced today its selection of Representative Richard E. Neal (D - MA) as Legislator of the Year for 2008-2009. Congressman Neal will receive the award this evening at 6 p.m.
"BIO commends Congressman Neal for his leadership and support of the crucial issues affecting the biotechnology industry. As Chairman of the Ways and Means Select Revenue Subcommittee, his competent understanding of the tax policies that encourage innovation and investment in tomorrow's technologies were critical to the expansion of America's prosperity," said BIO President and CEO Jim Greenwood. "We also thank him for support of the provision in the Economic Recovery Act, which increased funding at the National Institutes of Health by $10 billion over the next 2 years."
"The life sciences industry provides 45,000 jobs in the Commonwealth of Massachusetts, which makes it one of the largest and most developed biotech sectors in the United States. Representative Neal understands the challenges facing our biotechnology industry, especially emerging companies, in the current economic environment. We thank him for his outstanding leadership on behalf of the biotechnology industry in Massachusetts and throughout our country," said Robert Coughlin, President and CEO of the Massachusetts Biotechnology Council.
During the BIO Legislative Day Fly-In, more than 250 biotechnology industry representatives from 36 states, including Massachusetts, will participate in hundreds of meetings with key Members of the House and Senate. Participants will discuss issues critical to the biotechnology industry, including biosimilars, Food and Drug Administration appropriations, biofuels, and patent reform.
